Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001224948 | SCV001397177 | benign | Adams-Oliver syndrome 5 | 2024-11-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001587253 | SCV001816342 | uncertain significance | not provided | 2023-08-31 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function |
Genome- |
RCV001224948 | SCV002553996 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271197 | SCV002553998 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004032525 | SCV005027344 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-27 | criteria provided, single submitter | clinical testing | The p.R207H variant (also known as c.620G>A), located in coding exon 4 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 620. The arginine at codon 207 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |